TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE)
$34.64 -0.68 (-1.9253%)
Analysed TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) News Sources
Teva TD Findings Highlight Underdiagnosis And Shape Neuroscience Growth Story
20-05-2026
yahoo.com
The European Medicines Agency Accepts Teva’s Marketing Authorization Application for Olanzapine Long-Acting Injectable (TEV-‘749) for the Treatment of Schizophrenia in Adults
21-05-2026
yahoo.com
TEVA's MAA for Olanzapine LAI in Schizophrenia Accepted in the EU
22-05-2026
yahoo.com
Interact Enters a New Era of Growth with Brand Evolution, AI Innovation, and Industry Recognition
27-05-2026
yahoo.com
/C O R R E C T I O N -- Veeva Systems/
27-05-2026
yahoo.com
J&J Stock Gains Nearly 12% Year to Date: Buy, Sell or Hold Now?
28-05-2026
yahoo.com
A Look At Teva (TEVA) Valuation After New Real World Tardive Dyskinesia Data Release
30-05-2026
yahoo.com
Teva Pharmaceutical Industries Just Pulled Off One of Pharma's Most Impressive Comebacks
01-06-2026
fool.com
Is Veeva (VEEV) Quietly Redefining Its Moat With Deeper AI-Driven Life Sciences Integration?
01-06-2026
yahoo.com
Teva to Present at the Goldman Sachs Global Healthcare Conference
01-06-2026
yahoo.com
What is the current price of TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE)?
The current price of TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) is $34.64.
TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) absolute price change since previous trading day?
The absolute price change of TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) since the previous trading day is $-0.68.
TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) percentage price change since previous trading day?
The percentage price change of TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) since the previous trading day is -1.9253%.
What is the most recent average sentiment score for TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE)?
The most recent average sentiment score for TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) is 74 out of 100.
What is the most recent average sentiment for TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE)?
The most recent sentiment for TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) is .
SEC-8K** Filing Available For TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.